BELLUS Health (NASDAQ:BLU) Target Raised by Royal Bank of Canada to $9.00

StockMarketDaily.co reports: BELLUS Health stock has undergone multiple analysts rating changes in the recent past.  BELLUS Health stock Target Raised by   Royal Bank of Canada on 10/18/2021. In a note to investors, the firm issued a new target price of $9.00. The analysts previously had $8.00 target price.

View More BELLUS Health (NASDAQ:BLU) Target Raised by Royal Bank of Canada to $9.00